Alterity Therapeutics Limited Share Price
NASDAQ: ATHEAlterity Therapeutics Limited Stock Performance
Alterity Therapeutics Limited Share Price Today
As of 29 October 2026, Alterity Therapeutics Limited's share price is $2.06. The stock opened at $2.06, compared to its previous close of $2.01. During today's trading session, Alterity Therapeutics Limited's share price traded between $2.06 and $2.06, with an average price of $2.06. Over the past 52 weeks, the stock has recorded a high of $5.66 and a low of $2.01. In terms of performance, Alterity Therapeutics Limited's share price has declined by 55.22% over the last six months and is down 55.41% on a year-on-year basis.
Alterity Therapeutics Limited Share Price Chart
About Alterity Therapeutics Limited
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment: research and development into Parkinsonian and other neurodegenerative disorders.
Alterity Therapeutics Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $3.36 | $2.06 | -45.36% |
Sep 2026 | $4.51 | $3.77 | -17.14% |
Aug 2026 | $4.70 | $4.55 | +5.32% |
Jul 2026 | $5.53 | $4.32 | -20.44% |
Jun 2026 | $4.01 | $5.43 | +35.75% |
May 2026 | $4.75 | $4.00 | -13.04% |
Apr 2026 | $3.86 | $4.60 | +25.68% |
Mar 2026 | $3.41 | $3.66 | +5.17% |
Feb 2026 | $3.49 | $3.48 | +11.90% |
Jan 2026 | $3.20 | $3.11 | -0.96% |
Dec 2025 | $3.27 | $3.14 | -17.04% |
Nov 2025 | $4.05 | $3.79 | -18.07% |